Search Research Articles
Browse Research Categories

Selank Peptide Research

Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) analog of the endogenous immunopeptide tuftsin, developed in Russia and studied for its anxiolytic, nootropic, and immunomodulatory properties — without the sedation, dependence, or cognitive blunting associated with benzodiazepines or conventional anxiolytics. Research has documented its effects on GABA-A receptor modulation, BDNF upregulation, enkephalin system enhancement, and cytokine balance. Studies have explored its applications in anxiety, PTSD, depression, cognitive enhancement, and immune regulation. Its clean tolerability profile distinguishes it from most pharmaceutical anxiolytics in the research literature. This section covers scientific studies on Selank and its neurological, anxiolytic, and immunomodulatory peptide research applications.

Other Popular Research Categories

Newest Selank Research

Selank Peptide Research – Complete Guide

Selank is a synthetic heptapeptide developed by the Russian Academy of Sciences and studied for anxiolytic effects that appear to work without causing sedation or tolerance. This guide covers Selank peptide research across GABAergic modulation, BDNF upregulation, cognitive enhancement, immunomodulation, and clinical findings from human trials. Human data remains limited to small Russian studies, and Selank is classified for research...

About The Cenexa Labs Research Library

This section of the research library focuses on scientific studies involving and related research. The Cenexa Research Library compiles publicly available scientific literature and research summaries related to peptides, bioregulators, and signaling molecules. Our goal is to make complex scientific research easier to understand without requiring a technical background.
Scroll to Top
0